Evidence map›Paper›PMID 35600498›Full record

ReviewIndian journal of thoracic and cardiovascular surgery2022

COVID-19 Vaccination in Lung Transplant Recipients.

Eric Altneu, Aaron Mishkin

Open access · bronzeAbstract readReview
In one paragraph

Review in Indian journal of thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. COVID-19 vaccination and lung transplant recipients.Indian journal of thoracic and cardiovascular surgery · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric AltneuDepartment of Internal Medicine, Division of Infectious Diseases, Temple University Health System, Philadelphia, PA USA.ORCID 0000-0001-7703-0951
Aaron MishkinDepartment of Internal Medicine, Division of Infectious Diseases, Temple University Health System, Philadelphia, PA USA.
Temple University Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung transplant patients are at increased risk of infection due to immunosuppression. Vaccination is a key source of protection; however, after transplant, patients tend to have diminished host response. This is an important concern given the ongoing coronavirus disease 2019 (COVID-19) pandemic. Less is known about how transplant patients respond to COVID-19 vaccination and how best to approach immunization in the setting of a global pandemic. Lung transplant patients, and solid organ transplant patients as whole, have a less robust immune response after COVID-19 vaccination. This article reviews the literature on vaccine immune response in transplant patients with a focus on COVID-19 vaccination and international society guidelines.

Indexed as

COVID-19ImmunosuppressionTransplantVaccination

Identifiers

PMID35600498
PMCPMC9112254
OpenAlexW4280549184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.